- Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874
Yongtao Lin et al, 2020, BMC Pharmacology and Toxicology CrossRef - Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
Guokai Zhang et al, 2023, Frontiers in Genetics CrossRef - Five Constituents Contributed to the Psoraleae Fructus-Induced Hepatotoxicity via Mitochondrial Dysfunction and Apoptosis
Zhaojuan Guo et al, 2021, Frontiers in Pharmacology CrossRef - Carbon Monoxide-Releasing Molecule-3 Enhances Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells via miR-195-5p/Wnt3a Pathway
Jingyuan Li et al, 2022, Drug Design, Development and Therapy CrossRef - A Review of the Pharmacological Properties of Psoralen
Yali Ren et al, 2020, Frontiers in Pharmacology CrossRef - Alternative Medical Therapy
Jawahar Tulsidas Jethwa, 2023, Indian Journal of Orthopaedics CrossRef - Psoralen accelerates osteogenic differentiation of human bone marrow mesenchymal stem cells by activating the TGF‑β/Smad3 pathway
Yongquan Huang et al, 2021, Experimental and Therapeutic Medicine CrossRef - Osteogenesis promotion by injectable methacryloylated gelatin containing psoralen and its bacteriostatic properties
Qi Zhang et al, 2023, IET Nanobiotechnology CrossRef